Last reviewed · How we verify
Regional analgesia and propofol — Competitive Intelligence Brief
phase 3
Local anesthetic + sedative-hypnotic combination
Anesthesiology / Perioperative Medicine
Small molecule
Live · refreshed every 30 min
Target snapshot
Regional analgesia and propofol (Regional analgesia and propofol) — The Cleveland Clinic. Regional analgesia with propofol combines local anesthetic nerve blockade with intravenous sedation to provide perioperative pain control and anxiolysis.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Regional analgesia and propofol TARGET | Regional analgesia and propofol | The Cleveland Clinic | phase 3 | Local anesthetic + sedative-hypnotic combination |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Local anesthetic + sedative-hypnotic combination class)
- The Cleveland Clinic · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Regional analgesia and propofol CI watch — RSS
- Regional analgesia and propofol CI watch — Atom
- Regional analgesia and propofol CI watch — JSON
- Regional analgesia and propofol alone — RSS
- Whole Local anesthetic + sedative-hypnotic combination class — RSS
Cite this brief
Drug Landscape (2026). Regional analgesia and propofol — Competitive Intelligence Brief. https://druglandscape.com/ci/regional-analgesia-and-propofol. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab